A PARADIGM SHIFT IN EARLY DRUG DEVELOPMENT: INDIVIDUALIZING TO MORE PATIENT BENEFIT

The role of tumor/molecular target selection in the success of a new agent

C. Dittrich

Please set the zoomlevel of your browser to 100%.